Advertisement
SLDB vs STRO
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLDB is a StrongBuy and STRO is a StrongBuy.
SLDB's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for SLDB turned positive on October 21, 2026. Looking at past instances where SLDB's MACD turned positive, the stock continued to rise in 40 of 45 cases over the following month. The odds of a continued upward trend are 89%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SLDB's RSI Indicator exited the oversold zone, 35 of 41 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 55 cases where SLDB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.
Following a +8.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where SLDB advanced for three days, in 203 of 256 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
SLDB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The 10-day moving average for SLDB crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SLDB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for SLDB entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 19 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 31 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.837) is normal, around the industry mean (2.988). P/E Ratio (-3.392) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. SLDB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SLDB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
STRO's RSI Oscillator slumps into oversold zone
The RSI Indicator for STRO moved into overbought territory on October 21, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +5.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where STRO advanced for three days, in 209 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
STRO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on STRO as a result. In 74 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for STRO turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 38 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
The 50-day moving average for STRO moved below the 200-day moving average on September 17, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where STRO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for STRO entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-1.732) is normal, around the industry mean (2.988). P/E Ratio (-0.621) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (3.982) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. STRO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STRO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
SLDB | STRO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 64 | 7 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 31 Undervalued | 25 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 100 | |
PRICE GROWTH RATING 1..100 | 65 | 65 | |
P/E GROWTH RATING 1..100 | 19 | 9 | |
SEASONALITY SCORE 1..100 | 23 | 11 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
STRO's Valuation (25) in the Pharmaceuticals Major industry is in the same range as SLDB (31) in the Biotechnology industry. This means that STRO’s stock grew similarly to SLDB’s over the last 12 months.
STRO's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as SLDB (100) in the Biotechnology industry. This means that STRO’s stock grew similarly to SLDB’s over the last 12 months.
SLDB's SMR Rating (98) in the Biotechnology industry is in the same range as STRO (100) in the Pharmaceuticals Major industry. This means that SLDB’s stock grew similarly to STRO’s over the last 12 months.
SLDB's Price Growth Rating (65) in the Biotechnology industry is in the same range as STRO (65) in the Pharmaceuticals Major industry. This means that SLDB’s stock grew similarly to STRO’s over the last 12 months.
STRO's P/E Growth Rating (9) in the Pharmaceuticals Major industry is in the same range as SLDB (19) in the Biotechnology industry. This means that STRO’s stock grew similarly to SLDB’s over the last 12 months.
| SLDB | STRO | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 85% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 87% | 1 day ago 79% |
| Momentum ODDS (%) | N/A | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 89% | 1 day ago 84% |
| TrendWeek ODDS (%) | 1 day ago 83% | 1 day ago 83% |
| TrendMonth ODDS (%) | 1 day ago 86% | 1 day ago 90% |
| Advances ODDS (%) | 1 day ago 79% | 2 days ago 83% |
| Declines ODDS (%) | 8 days ago 89% | 8 days ago 89% |
| BollingerBands ODDS (%) | 1 day ago 79% | 1 day ago 82% |
| Aroon ODDS (%) | 1 day ago 89% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
SLDB’s FA Score shows that 2 FA rating(s) are green while STRO’s FA Score has 2 green FA rating(s).
- SLDB’s FA Score: 2 green, 3 red.
- STRO’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
SLDB’s TA Score shows that 5 TA indicator(s) are bullish while STRO’s TA Score has 4 bullish TA indicator(s).
- SLDB’s TA Score: 5 bullish, 3 bearish.
- STRO’s TA Score: 4 bullish, 5 bearish.
Price Growth
SLDB (@Biotechnology) experienced а +17.29% price change this week, while STRO (@Biotechnology) price change was +2.57% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +1.90%. For the same industry, the average monthly price growth was -15.91%, and the average quarterly price growth was -14.30%.
Reported Earning Dates
SLDB is expected to report earnings on Nov 02, 2026.
STRO is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Biotechnology (+1.90% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FDFF | 36.00 | 0.24 | +0.66% |
| Fidelity Disruptive Finance ETF (FDFF) | |||
| IDEF | 30.40 | 0.17 | +0.55% |
| iShares Defense Industrials and Tech Active ETF (IDEF) | |||
| NFLT | 22.14 | 0.03 | +0.11% |
| Virtus Newfleet Multi-Sector Bond ETF (NFLT) | |||
| UUUG | 1.38 | N/A | N/A |
| Leverage Shares 2X Long UUUU Daily ETF (UUUG) | |||
| GDXD | 22.76 | -0.49 | -2.11% |
| MicroSectors Gold Miners - 3X Inverse Leveraged ETNs (GDXD) | |||
SLDB and
Correlation & Price change
A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with EDIT. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then EDIT could also see price increases.
| Ticker / NAME | Correlation To SLDB | 1D Price Change % | ||
|---|---|---|---|---|
| SLDB | 100% | +0.16% | ||
| EDIT - SLDB | 61% Loosely correlated | -2.71% | ||
| RCKT - SLDB | 55% Loosely correlated | -5.98% | ||
| IMTX - SLDB | 53% Loosely correlated | +2.40% | ||
| BEAM - SLDB | 53% Loosely correlated | -0.36% | ||
| FDMT - SLDB | 52% Loosely correlated | -3.66% | ||
More | ||||
STRO and
Correlation & Price change
A.I.dvisor indicates that over the last year, STRO has been loosely correlated with EDIT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if STRO jumps, then EDIT could also see price increases.
| Ticker / NAME | Correlation To STRO | 1D Price Change % | ||
|---|---|---|---|---|
| STRO | 100% | -6.50% | ||
| EDIT - STRO | 38% Loosely correlated | -2.71% | ||
| CADL - STRO | 37% Loosely correlated | -3.13% | ||
| TSHA - STRO | 36% Loosely correlated | +0.24% | ||
| SLDB - STRO | 36% Loosely correlated | +0.16% | ||
| AXON - STRO | 35% Loosely correlated | +2.54% | ||
More | ||||